Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial - sprookjes - yvandenbroek - TriplyDB

Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial

Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial

http://www.wikidata.org/entity/Q28293803

about

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia Update on management of Barrett's esophagus Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance Comparison of Tissue Architectural Changes between Radiofrequency Ablation and Cryospray Ablation in Barrett's Esophagus Using Endoscopic Three-Dimensional Optical Coherence Tomography.Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis.Ablative therapy for esophageal dysplasia and early malignancy: focus on RFA.Role of Confocal Laser Endomicroscopy in Detection of Residual Barrett's Esophagus after Radiofrequency Ablation Prevention of esophageal strictures after endoscopic submucosal dissection Durability and predictors of successful radiofrequency ablation for Barrett's esophagus.Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation.Barrett's Esophagus without dysplasia: wait or ablate?Evidence-based endoscopic management of Barrett's esophagus Detection of intestinal metaplasia after successful eradication of Barrett's Esophagus with radiofrequency ablation.Esophageal papilloma: Flexible endoscopic ablation by radiofrequency.Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos).The cost effectiveness of radiofrequency ablation for Barrett's esophagus.Endoscopic Optical Coherence Tomography for Clinical Gastroenterology Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett's esophagus radiofrequency ablation treatment response (with videos).Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium Radiofrequency ablation in the management of Barrett's esophagus - preliminary own experience.Recurrent intestinal metaplasia at the gastroesophageal junction following endoscopic eradication of dysplastic Barrett's esophagus may not be benign Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation.Depth-resolved imaging of colon tumor using optical coherence tomography and fluorescence laminar optical tomography.Risk stratification for malignant progression in Barrett's esophagus: Gender, age, duration and year of surveillance Managing Barrett's esophagus with radiofrequency ablation Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.Current state of endoscopic therapies in Barrett's esophagus and esophageal cancer.Endoscopic management of Barrett esophagus.Endoscopic therapies for the prevention and treatment of early esophageal neoplasia.Endoscopic therapy for Barrett's esophagus: a review of its emerging role in optimal diagnosis and endoluminal therapy.Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions.Endotherapy for Barrett's esophagus.Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.Endoscopic therapies for Barrett's-associated dysplasia: a new paradigm for a new decade.Molecular biomarkers and ablative therapies for Barrett's esophagus.

P2860

Q24621075-DDD1BE5C-9C66-46ED-BFF7-444E3DA47491 Q26751160-35020000-4959-4DEB-B6BC-11EB1A4D91C5 Q26821767-C7339C8D-0A69-49F7-840B-FA90EEDFCE65 Q27008431-7291479E-2AF1-4A96-B2DB-745CF0ED6535 Q30521404-50B7DDBE-153D-47C3-ACF0-A6C5DB3F642D Q33746567-CBDFA7F6-5B01-47D6-9722-9633CD2EAD43 Q34029709-D2FA21DF-E58E-4F8B-A31A-11E6C26BA19D Q34273998-94623379-B3D9-4E76-BFA5-FF6C41662F13 Q34467151-EB1F09D3-81B2-47F0-AC18-D3FDD9836CC2 Q34476331-D8E222FF-3DC1-48EB-8638-7F53BC76B054 Q34933881-BBDDDCB3-DDB8-435B-9B71-172A8ED7DBB6 Q35042727-9BB64A78-119B-4EC9-9E98-2F9D03DAE774 Q35074266-D2B5A570-4D6E-4FE0-8F37-0E009E0B9BE6 Q35129284-30D06346-57A1-4554-B0C2-DB54C6D6E5A2 Q35179285-DFD0050C-9EF2-41A1-A860-6F88DBD2B8E2 Q35662212-4E4163C2-7205-40E0-A09D-DE9637CDE08F Q35863931-5F2FE7A8-244D-4FC5-9256-763820B720F9 Q35891829-A73F3CB3-AAD0-4072-9AAF-44E1626C2257 Q36093101-BCCC4AC0-7FCA-409A-B74F-7A02BDBB177F Q36195501-D191B3DE-4B1E-4B8D-AC45-B9E9C26C206A Q36335185-015CE7E7-C729-46E6-83C5-00403A4D3C3E Q36360665-CC495226-35EE-4ED8-9EA2-48A09D9A43E3 Q36921955-F3A79DC5-4FDA-427F-873F-62CD1C445481 Q36966394-B21BA9E4-7A3E-4F5F-BCCA-F76DE9C62ECE Q36977169-2B819CE4-7118-49CB-AA4C-AC95BF0D7F1F Q37184141-78B5B963-D5EB-45C7-90DB-DE1F82A5D335 Q37257157-7CDF3ED4-A8D0-4712-AA3B-20E5AF04FB5F Q37523763-CCFA08D3-600D-430D-ABC2-EB9BA0718432 Q37538933-A288AF92-2A30-456D-849F-F2D71BCC2E70 Q37609156-97E6711F-6DD2-4C5A-A4FA-EC6744145D6F Q37633568-EE7ABF9B-A6A0-4C72-A25D-1737C9A9AB94 Q37858383-5CB58571-FA2F-452B-B92B-EA139EED86EE Q37926908-D1941BBD-1B8C-4A5A-BB45-B5B9B0DF873A Q37948157-1740E730-DC6F-4453-99F5-840370DBAB99 Q37967405-A411BE06-EB49-4034-B7A5-63D0A4A8028D Q37967701-6FE1A1B8-2246-4A38-BD8F-8C94B876B79B Q38001289-B63B3A95-F052-46EF-87A8-2FF4A775CD18 Q38005810-469D98E2-F731-4F6F-8D21-EBEB640896D4 Q38014493-4CDB7A28-A439-40F0-A572-E8C1146B35C7 Q38051702-6E6546A2-E805-48AE-924D-98B35DD2C652

P2860

Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial

http://www.wikidata.org/entity/Q28293803

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Endoscopic radiofrequency abla ...... prospective multicenter trial

@ast

Endoscopic radiofrequency abla ...... prospective multicenter trial

@en

Endoscopic radiofrequency abla ...... prospective multicenter trial

@nl

type

label

Endoscopic radiofrequency abla ...... prospective multicenter trial

@ast

Endoscopic radiofrequency abla ...... prospective multicenter trial

@en

Endoscopic radiofrequency abla ...... prospective multicenter trial

@nl

prefLabel

Endoscopic radiofrequency abla ...... prospective multicenter trial

@ast

Endoscopic radiofrequency abla ...... prospective multicenter trial

@en

Endoscopic radiofrequency abla ...... prospective multicenter trial

@nl

P1433

Q28293803-66ABF7BB-A3F7-43B1-8A81-5E4293E17852

P1476

Q28293803-DF4DB504-F248-4FB1-B366-FE4F37A55DA8

P2093

Q28293803-064C7CC7-FA23-4C96-889E-C6D65EDA1704

Q28293803-0C0B9805-0D27-4269-ACC9-708A0EA02811

Q28293803-2DB006E1-9971-40CF-BEB6-5834B9C91DF5

Q28293803-3B52BC2F-D661-493B-B01E-7E167C552385

Q28293803-4117B2EC-3F30-4094-91A5-7D65C79448B1

Q28293803-493C1E90-C78B-4908-9EED-710D06165A60

Q28293803-89CDC343-642F-49B1-93FB-E5DFE6373691

Q28293803-93BCF948-AA9F-43C0-910D-1999BEC43975

Q28293803-9B0DA17D-6650-4D13-A581-6F252598B0FE

Q28293803-9B5EC955-40FA-45B3-BCF2-04705F403DB8

P304

Q28293803-B50EA6DE-2D4F-4820-B9DB-21C2B79F4CCD

P31

Q28293803-E56565BF-C4C9-4113-BC67-73124576B7ED

P3181

Q28293803-428D8348-EC44-4C96-A201-4AE817C49106

P356

Q28293803-BA9121F9-0615-4202-9C5C-0BBC9B5CCDF3

P407

Q28293803-06E0E288-71E6-45B6-A14A-987682ACD8CB

P433

Q28293803-125AD124-EA5F-46EE-8124-E15FD7486E37

P478

Q28293803-F48325F7-86F6-4EE9-A2F3-209BA99B909E

P50

Q28293803-652F60DF-2896-4BE7-A0B7-20F07ADDEE3A

P577

Q28293803-24504A10-F4B6-4F86-A187-55B910126F06

P5875

Q28293803-FA396E25-ED78-40DF-B356-4CD161ABFC4D

P698

Q28293803-CA4E06C7-73A5-4A9F-9C93-035463374D06

P921

Q28293803-BD4E3A81-5C4B-49C2-9CC2-823AE54A760E

P3181

P356

P1433

P1476

Endoscopic radiofrequency abla ...... prospective multicenter trial

@en

P2093

A Reymunde

http://www.w3.org/2001/XMLSchema#string

B F Overholt

http://www.w3.org/2001/XMLSchema#string

C J Lightdale

http://www.w3.org/2001/XMLSchema#string

D E Fleischer

http://www.w3.org/2001/XMLSchema#string

K J Chang

http://www.w3.org/2001/XMLSchema#string

K K Wang

http://www.w3.org/2001/XMLSchema#string

M B Kimmey

http://www.w3.org/2001/XMLSchema#string

N Santiago

http://www.w3.org/2001/XMLSchema#string

P J Dean

http://www.w3.org/2001/XMLSchema#string

R Chuttani

http://www.w3.org/2001/XMLSchema#string

P304

781-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2274914

http://www.w3.org/2001/XMLSchema#string

P356

10.1055/S-0030-1255779

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Douglas K. Pleskow

P577

2010-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46382876

http://www.w3.org/2001/XMLSchema#string

P698

20857372

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial